
This review summarizes experimental models of uveal melanoma, including 2D cell cultures, 3D spheroids and organoids, animal models, and emerging platforms. These models facilitate investigations of molecular mechanisms, metastasis, diagnostics, and therapeutics, but differ in their ability to recapitulate genetic fidelity, tumor microenvironment, and immune interactions, as well as in cost and time. Selecting and combining complementary models based on specific research questions can strengthen biological relevance and translational research. Created with http://biorender.com/.
ABSTRACT
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and is characterized by a high propensity for metastatic dissemination, particularly to the liver, which remains largely incurable. Despite advances in the molecular characterization of UM, progress in therapeutic development has been limited, in part due to the lack of preclinical models that faithfully recapitulate the biological complexity and clinical behavior of the disease. A wide range of in vitro and in vivo systems have been developed, including primary cultures and established cell lines, three-dimensional (3D) cultures, patient-derived organoids (PDOs), xenografts, and genetically engineered animal models. Each of these models captures specific aspects of UM biology but also presents inherent limitations related to genetic drift, microenvironmental context, immune interactions, and metastatic fidelity. In this review, we provide an overview of current preclinical models used to study UM, with a focus on the strengths and limitations of each system. We also discuss emerging strategies to improve model fidelity and translational relevance. Continued development of integrated and physiologically relevant models will be essential to bridge the gap between discovery and clinical application in UM.
Leggi l'articolo originale su Pigment Cell & Melanoma Research